[go: up one dir, main page]

HRP980231B1 - Phosphodiesterase 4 - inhibiting diazepinoindolones - Google Patents

Phosphodiesterase 4 - inhibiting diazepinoindolones

Info

Publication number
HRP980231B1
HRP980231B1 HR980231A HRP980231A HRP980231B1 HR P980231 B1 HRP980231 B1 HR P980231B1 HR 980231 A HR980231 A HR 980231A HR P980231 A HRP980231 A HR P980231A HR P980231 B1 HRP980231 B1 HR P980231B1
Authority
HR
Croatia
Prior art keywords
formula
compounds
phosphodiesterase
diazepinoindolones
inhibiting
Prior art date
Application number
HR980231A
Other languages
English (en)
Inventor
Yves Pascal
Catherine Burnouf
Bernard Gaudilliere
Henry Jacobelli
Alain Calvet
Adrian Payne
Sven G Dahl
Original Assignee
Jouveinal S C A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal S C A filed Critical Jouveinal S C A
Publication of HRP980231A2 publication Critical patent/HRP980231A2/hr
Publication of HRP980231B1 publication Critical patent/HRP980231B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR980231A 1997-04-30 1998-04-29 Phosphodiesterase 4 - inhibiting diazepinoindolones HRP980231B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705422A FR2762841B1 (fr) 1997-04-30 1997-04-30 Diazepino-indolones inhibitrices de phosphodiesterases iv

Publications (2)

Publication Number Publication Date
HRP980231A2 HRP980231A2 (en) 2000-04-30
HRP980231B1 true HRP980231B1 (en) 2002-06-30

Family

ID=9506517

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980231A HRP980231B1 (en) 1997-04-30 1998-04-29 Phosphodiesterase 4 - inhibiting diazepinoindolones

Country Status (17)

Country Link
US (1) US6239130B1 (fr)
EP (1) EP0980374B1 (fr)
JP (1) JP2001522367A (fr)
KR (1) KR20010020386A (fr)
AT (1) ATE232534T1 (fr)
AU (1) AU729495B2 (fr)
BR (1) BR9809429A (fr)
CA (1) CA2278217A1 (fr)
DE (1) DE69811360T2 (fr)
DK (1) DK0980374T3 (fr)
ES (1) ES2190083T3 (fr)
FR (1) FR2762841B1 (fr)
HR (1) HRP980231B1 (fr)
MX (1) MXPA99006979A (fr)
NZ (1) NZ337589A (fr)
WO (1) WO1998049169A1 (fr)
ZA (1) ZA983704B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795731B1 (fr) * 1999-07-02 2001-09-07 Warner Lambert Co PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES
AU3217501A (en) * 2000-03-03 2001-09-12 Pfizer Prod Inc Pyrazole ether derivatives as anti-inflammatory/analgesic agents
EP1161949A1 (fr) 2000-06-09 2001-12-12 Warner-Lambert Company Utilisation de diazepino-indoles dans le traitement des bronchopneumopathies chroniques obstructive
EP1188438A1 (fr) * 2000-09-15 2002-03-20 Warner-Lambert Company Compositions pharmaceutiques pour la prévention ou le traitement de maladies associées à un excès de production de l' IL-12
EP1199074A1 (fr) * 2000-09-15 2002-04-24 Warner-Lambert Company Composition pharmaceutique pour la prévention ou le traitement de maladies associées à un excès de production d' IL-12
EP1389467B1 (fr) 2001-05-23 2013-07-03 Mitsubishi Tanabe Pharma Corporation Composition thérapeutique permettant le traitement régénératif des maladies de cartilage
WO2002094321A1 (fr) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions favorisant la guérison d'une fracture osseuse
AU2002317377A1 (en) * 2001-07-20 2003-03-03 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
US20090042951A1 (en) * 2004-02-20 2009-02-12 Robert Danziger Blood Pressure Reduction in Salt-Sensitive Hypertension
KR20070007945A (ko) * 2004-04-23 2007-01-16 셀진 코포레이션 폐 고혈압증의 치료 및 관리를 위한 ｐｄｅ4 조절인자의사용 방법 및 그를 포함하는 조성물
EA016037B1 (ru) * 2005-04-19 2012-01-30 Никомед Гмбх Рофлумиласт для лечения лёгочной гипертензии
MX2009003673A (es) * 2006-10-04 2009-04-22 Pfizer Prod Inc Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio.
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
CN101641094A (zh) * 2007-04-11 2010-02-03 爱尔康研究有限公司 TNFα抑制剂联合抗组胺药治疗变应性鼻炎和变应性结膜炎的用途
KR20100037047A (ko) * 2007-06-26 2010-04-08 렉시컨 파마슈티컬스 인코퍼레이티드 세로토닌-매개 질환 및 장애의 치료 방법
BR112012007091A2 (pt) * 2009-10-01 2016-04-19 Alcon Res Ltd composições de olopatadina e seus usos
MX2021007938A (es) 2018-12-28 2022-01-24 Regeneron Pharma Tratamiento de trastornos respiratorios con inhibidores de la araquidonato 15-lipooxigenasa (alox15).

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv

Also Published As

Publication number Publication date
MXPA99006979A (es) 2005-04-19
EP0980374B1 (fr) 2003-02-12
FR2762841B1 (fr) 1999-07-02
DK0980374T3 (da) 2003-05-05
DE69811360T2 (de) 2003-10-09
ATE232534T1 (de) 2003-02-15
BR9809429A (pt) 2000-06-13
DE69811360D1 (de) 2003-03-20
AU7765298A (en) 1998-11-24
ZA983704B (en) 1999-10-25
JP2001522367A (ja) 2001-11-13
KR20010020386A (ko) 2001-03-15
AU729495B2 (en) 2001-02-01
EP0980374A1 (fr) 2000-02-23
WO1998049169A1 (fr) 1998-11-05
HRP980231A2 (en) 2000-04-30
US6239130B1 (en) 2001-05-29
FR2762841A1 (fr) 1998-11-06
NZ337589A (en) 2000-10-27
CA2278217A1 (fr) 1998-11-05
ES2190083T3 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
HRP980231B1 (en) Phosphodiesterase 4 - inhibiting diazepinoindolones
PL314605A1 (en) Isoxazolin compounds as anti-inflammatory agents
GR3032506T3 (en) 3-aryl-2-isoxazolines as antiinflammatory agents
MX9805016A (es) INHIBIDORES DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1 beta.
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
WO2003041643A3 (fr) Composes de zearalanol inhibant hsp90 et leurs procedes de production et d'utilisation
EP1034164A4 (fr) Derives d'alanine-beta agissant en tant qu'inhibiteurs de l'adhesion cellulaire
BG104138A (en) 2-aminopyridines containing substituents with condensed rings as nos inhibitors
WO2004054501A3 (fr) Compositions comprenant un (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide et methodes d'utilisation de ces compositions
CA2293382A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents anti-inflammatoires
SI1480961T1 (sl) Inhibitorji dpiv na osnovi glutaminila
IL112847A (en) Isoxazoline compounds as inhibitors of tnf release
WO2001035950A3 (fr) Agent therapeutique a base d'amide et procedes de traitement des affections intestinales inflammatoires
MY122278A (en) 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
BG102818A (en) D-manitol and method for its preparation
AP2000001992A0 (en) Succinamide inhibitors of inteleukin-1B converting enzyme.
IL117209A (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
EP1032556A4 (fr) Composes pharmaceutiquement actifs et procedes d'utilisation
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
PL358552A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
DE69929802D1 (en) Lta4 hydrolase-hemmer
MX9805015A (es) INHIBIDORES DE LA ENZIMA QUE CONVIERTE LA INTERLEUCINA-1 beta.
HK1073599A (en) Immunosuppressant compounds, methods and uses related thereto

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040429

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20050430